002626 Stock Overview
Engages in the manufacturing and sale of the nutrition and health products in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Xiamen Kingdomway Group Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.58 |
| 52 Week High | CN¥17.88 |
| 52 Week Low | CN¥10.71 |
| Beta | 0.90 |
| 1 Month Change | 0.26% |
| 3 Month Change | 17.14% |
| 1 Year Change | -2.14% |
| 3 Year Change | -51.33% |
| 5 Year Change | -20.10% |
| Change since IPO | 112.97% |
Recent News & Updates
We Think Xiamen Kingdomway Group (SZSE:002626) Can Manage Its Debt With Ease
Sep 27
Market Participants Recognise Xiamen Kingdomway Group Company's (SZSE:002626) Earnings
Aug 23Recent updates
We Think Xiamen Kingdomway Group (SZSE:002626) Can Manage Its Debt With Ease
Sep 27Market Participants Recognise Xiamen Kingdomway Group Company's (SZSE:002626) Earnings
Aug 23Xiamen Kingdomway Group (SZSE:002626) Has Affirmed Its Dividend Of CN¥0.20
May 31Is Xiamen Kingdomway Group (SZSE:002626) A Risky Investment?
May 28What Xiamen Kingdomway Group Company's (SZSE:002626) P/E Is Not Telling You
Apr 30Is Xiamen Kingdomway Group (SZSE:002626) Using Too Much Debt?
Feb 28Shareholder Returns
| 002626 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.7% | -1.0% | 0.4% |
| 1Y | -2.1% | -3.0% | 12.3% |
Return vs Industry: 002626 exceeded the CN Pharmaceuticals industry which returned -4.4% over the past year.
Return vs Market: 002626 underperformed the CN Market which returned 9.8% over the past year.
Price Volatility
| 002626 volatility | |
|---|---|
| 002626 Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 002626 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002626's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 2,126 | Bin Jiang | www.kingdomway.com |
Xiamen Kingdomway Group Company engages in the manufacturing and sale of the nutrition and health products in China and internationally. It offers its products under the Doctor’s Best, Zipfizz, Kingdomway, Labrada, Prosupps, Maikon, and Jinlexin brands. The company was formerly known as Xiamen Jindawei Vitamin Co., Ltd.
Xiamen Kingdomway Group Company Fundamentals Summary
| 002626 fundamental statistics | |
|---|---|
| Market cap | CN¥9.50b |
| Earnings (TTM) | CN¥253.95m |
| Revenue (TTM) | CN¥3.12b |
37.4x
P/E Ratio3.0x
P/S RatioIs 002626 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002626 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.12b |
| Cost of Revenue | CN¥1.96b |
| Gross Profit | CN¥1.17b |
| Other Expenses | CN¥915.14m |
| Earnings | CN¥253.95m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.42 |
| Gross Margin | 37.42% |
| Net Profit Margin | 8.13% |
| Debt/Equity Ratio | 26.8% |
How did 002626 perform over the long term?
See historical performance and comparisonDividends
1.3%
Current Dividend Yield49%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 06:09 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Xiamen Kingdomway Group Company is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiaqi Yu | China Merchants Securities Co. Ltd. |
| Zhe Wang | Citic Securities Co., Ltd. |
| Jie Yao | Everbright Securities Co. Ltd. |